1 minute read

ODRĘBNOŚCI W LECZENIU STARSZYCH CHORYCH

 Literatura

Dimopoulos MA, Moreau P, Terpos E i wsp.: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. HemaSphere 2021; 5: 2 (e528).

Advertisement

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–1403.

Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2010. http://seer.cancer.gov/ csr/1975_2010/2013.

McKenna RW, Kyle RA, Kuehl WM, Grogan TM, Harris NL, Coupland RW: Plasma cell neoplasms. w: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. (Eds.): WHO classification of tumours of haematopoietic and lymphoid tissues. IARC: Lyon 2008, str. 200–213.

Moreau P, San Miguel J, Sonneveld P i wsp.: Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017; 28(suppl_4):iv52-iv61.

Rajkumar SV, Dimopoulos MA, Palumbo A i wsp.: International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15: e538–48.

Siegel RL, Miller KD, Jema A: Cancer Statistics, 2016. CA Cancer J Clin 2016; 66: 7–30; DOI: 10.3322/caac.21332

Didkowska J, Wojciechowska U, Olasek P, dos Santos FC, Michałek I: Nowotwory złośliwe w Polsce w 2019 roku. Krajowy Rejestr Nowotworów, Warszawa 2021, http://onkologia.org.pl/raporty/.

This article is from: